about
Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cellsPhosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neuronsA missense mutation in KCTD17 causes autosomal dominant myoclonus-dystoniaPharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystoniaGenome-wide association study reveals genetic risk underlying Parkinson's diseaseStemBANCC: Governing Access to Material and Data in a Large Stem Cell Research ConsortiumBee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse modelLysosomal dysfunction in Parkinson disease: ATP13A2 gets into the grooveEpsilon-sarcoglycan mutations found in combination with other dystonia gene mutationsClinical and genetic features of myoclonus-dystonia in 3 cases: a video presentationThe phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 geneMutant Parkin impairs mitochondrial function and morphology in human fibroblastsBioenergetic consequences of PINK1 mutations in Parkinson diseasePINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncouplingComprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive Dystonia.Challenges of making music: what causes musician's dystonia?Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers.Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.Replication of association between ELAVL4 and Parkinson disease: the GenePD study.The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.Substantia nigra hyperechogenicity in DYT6 dystonia: a pilot studyMusician's dystonia and comorbid anxiety: two sides of one coin?The role of mutations in COL6A3 in isolated dystonia.Abnormal interhemispheric inhibition in musician's dystonia - Trait or state?Mutations in GNAL: a novel cause of craniocervical dystonia.Data protection in biomaterial banks for Parkinson's disease research: the model of GEPARD (Gene Bank Parkinson's Disease Germany).The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6).Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder.The curious case of phenocopies in families with genetic Parkinson's disease.Genetics of dystonia: what's known? What's new? What's next?Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study.Digitized spiral analysis is a promising early motor marker for Parkinson DiseaseMutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts.Phenotypic spectrum of musician's dystonia: a task-specific disorder?Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
P50
Q24300095-E6BD1BC5-35A9-4906-9FCC-DED5A383E9D3Q24305292-730F93E9-2E1A-44AF-B47D-29ADF5DC211BQ24337555-625FC59D-CEA9-4B31-B5E6-A0D507CF6710Q24339508-B065D1F5-A309-4EB3-9812-0270B419316FQ24616239-21A8472D-6B22-4616-B35B-553CFDDFC61DQ24646654-6A095201-F552-48DD-9126-F3E28D56D763Q26864136-491A5115-716B-4A3F-B97C-95DAB8EC404EQ27324290-AF61EBCF-A20F-4095-AFA6-B718504A74B1Q28115428-82D5F0E7-43C5-407A-8D28-BB7BDFAE6142Q28211248-CEB4FC0F-92E3-4D29-8CA9-57307E358322Q28246302-61EF86FA-C1B1-4986-A813-515294DF21D4Q28286980-B17534DC-6CAE-4D54-A8E3-7A40DBF68704Q28475596-7B57B9C4-6DDA-4C90-8B14-DE1D9203032FQ28477544-37B131FA-C5E0-4635-93C6-6673DCC9D3F0Q28593164-D08628A4-C8F6-4052-99DB-566D88F1EC43Q29417106-AB06F14D-134D-4B81-AA1A-19EEFD26CE5DQ30100991-E139DCAA-7C92-43E1-8ED0-19D447B47EE1Q30355479-9A6CF200-738B-486A-A8A7-209E7AB4A461Q30374480-7DB9E324-F287-4C1A-9BD3-17BC706AB588Q30438950-DACCB8D5-11B3-4C47-AFFE-82586AA6C7E1Q30439050-2C51DA74-CF95-44CE-976C-4CF0F38C3C27Q30440660-9CC74692-40DB-4D20-9715-BD427E537F99Q30448742-D7884447-AD53-4EE9-B349-2AFCD3F30005Q30474990-9587FF19-124F-4A95-9B4A-32A852A073C6Q30554445-56929A64-EA04-41AC-B991-AC446A09FC4BQ30570589-135B1E99-055A-4429-97A5-412C7E2C17FAQ30570685-F706E52B-08E3-4063-BF65-1360FACAC483Q30599478-8CC2E605-5D3E-41AC-91AF-E700A27408AEQ31093699-498673DC-75CE-49FD-A889-3E9759C116A9Q31814850-FDD15F13-AEB3-4A0D-9E6A-8B8D1051F051Q33344464-55545587-4351-4E91-B5D7-05DDECFB3941Q33351731-63407DC8-6ABC-49BC-B205-65A64FF1C73AQ33356255-AF42AD08-C1B5-4752-A030-171067FC13B8Q33514018-F295FA95-F759-4EA8-A2DF-696B08346D19Q33818010-0528C25F-64AD-4134-A835-490DD89802AEQ33821574-7B7B794E-3A37-465E-99BF-78185D880F84Q33847524-9F9C0E54-3B59-4D77-95E2-FD859E4487D0Q33861756-437C2699-7F36-4581-B100-4025A41317ADQ33939245-3D39EEE7-79C1-4238-9F25-95B5DBA16598Q34037141-19C62ABE-4541-4735-8723-48DB49EC689F
P50
description
Medizinerin
@de
physician
@en
name
Christine Klein
@ast
Christine Klein
@de
Christine Klein
@en
Christine Klein
@es
Christine Klein
@nl
كريستين كلاين
@ar
type
label
Christine Klein
@ast
Christine Klein
@de
Christine Klein
@en
Christine Klein
@es
Christine Klein
@nl
كريستين كلاين
@ar
prefLabel
Christine Klein
@ast
Christine Klein
@de
Christine Klein
@en
Christine Klein
@es
Christine Klein
@nl
كريستين كلاين
@ar